UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 487

Sortiert nach

Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer

Cancer science, 2020-09, Vol.111 (9), p.3268-3278

2020

Volltextzugriff (PDF)

Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy

Scientific reports, 2020-06, Vol.10 (1), p.9549-9549, Article 9549

2020

Volltextzugriff (PDF)

Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer

Journal of cancer research and clinical oncology, 2019-08, Vol.145 (8), p.2157-2166

2019

Volltextzugriff (PDF)

Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1

Frontiers in immunology, 2019-07, Vol.10, p.1760-1760

2019

Volltextzugriff (PDF)

Does awareness of terminal status influence survival and quality of life in terminally ill cancer patients?

Psycho-oncology (Chichester, England), 2013-10, Vol.22 (10), p.2206-2213

2013

Volltextzugriff (PDF)

TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma

Cancer letters, 2018-02, Vol.415, p.106-116

2018

Volltextzugriff (PDF)

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

BMC cancer, 2011-11, Vol.11 (1), p.489-489, Article 489

2011

Volltextzugriff (PDF)

BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin

Cancer science, 2010-05, Vol.101 (5), p.1247-1254

2010

Volltextzugriff (PDF)

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling

Cell death discovery, 2021-04, Vol.7 (1), p.65-13, Article 65

2021

Volltextzugriff (PDF)

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022-05, Vol.25 (3), p.609-618

2022

Volltextzugriff (PDF)

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e008638

2024

Volltextzugriff (PDF)

Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy

Japanese journal of clinical oncology, 2015-06, Vol.45 (6), p.541-546

2015

Volltextzugriff (PDF)

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α-TAK1-MMP9 axis

Cell death discovery, 2023-04, Vol.9 (1), p.122-122, Article 122

2023

Volltextzugriff (PDF)

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer

Clinical & experimental metastasis, 2014-01, Vol.31 (1), p.25-32

2014

Volltextzugriff (PDF)

Comparison of long‑term treatment outcomes of T2N0M0 laryngeal squamous cell carcinoma using different treatment methods

Oncology letters, 2020-07, Vol.20 (1), p.921-930

2020

Volltextzugriff (PDF)

Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2

PLoS genetics, 2020-05, Vol.16 (5), p.e1008796

2020

Volltextzugriff (PDF)

p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma

Oncology letters, 2018-05, Vol.15 (5), p.6571-6577

2018

Volltextzugriff (PDF)

Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients

World journal of gastroenterology : WJG, 2021-11, Vol.27 (42), p.7340-7349

2021

Volltextzugriff (PDF)

Bone remodeling by checkpoint inhibitor

The Korean Journal of Internal Medicine, 2020, 35(5), , pp.1258-1258

2020

Volltextzugriff (PDF)

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

Nature communications, 2022-10, Vol.13 (1), p.6002-6002, Article 6002

2022

Volltextzugriff (PDF)

A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting

BioMed research international, 2015-01, Vol.2015, p.523601-7

2015

Volltextzugriff (PDF)

Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation

Nature communications, 2024-04, Vol.15 (1), p.2919-2919, Article 2919

2024

Volltextzugriff (PDF)

Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer

American journal of clinical oncology, 2010-12, Vol.33 (6), p.624-628

2010

Volltextzugriff (PDF)

A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma

Frontiers in immunology, 2022-06, Vol.13, p.879452-879452

2022

Volltextzugriff (PDF)

Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy‐induced nausea and vomiting in Korean cancer patients

Asia-Pacific journal of clinical oncology, 2017-02, Vol.13 (1), p.53-60

2017

Volltextzugriff (PDF)

1 – 25 von 487

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(427)
Mit Volltextzugriff
(459)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(268)
Life Sciences & Biomedicine
(216)
Humans
(150)
Male
(103)
Female
(101)
Middle Aged
(89)
Oncology
(87)
Aged
(74)
Adult
(65)
Original
(48)
Medicine
(38)
Technology
(38)
Tumors
(36)
Chemotherapy
(35)
Prognosis
(35)
Treatment Outcome
(35)
Cancer
(33)
Medicine & Public Health
(33)
Animals
(32)
Science & Technology - Other Topics
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer

Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy

Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer

Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1

Does awareness of terminal status influence survival and quality of life in terminally ill cancer patients?

TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α-TAK1-MMP9 axis

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer

Comparison of long‑term treatment outcomes of T2N0M0 laryngeal squamous cell carcinoma using different treatment methods

Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2

p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma

Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients

Bone remodeling by checkpoint inhibitor

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting

Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation

Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer

A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma

Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy‐induced nausea and vomiting in Korean cancer patients

Suchergebnisse filtern